" />


Delivering rapid patient enrollment
Endocrine studies have become one of the most important studies as these diseases are on an exponential increase and are often linked with co-morbidities with cardiovascular diseases.

Some of the important factors in endocrine studies are:
  • Patient compliance
  • Changing regulatory guidelines in U.S.
  • Patient enrollment
  • Increase market access
  • Tracking co-morbidities

At SIRO, we leverage our experience and local knowledge to provide our clients with expedited patient recruitment, insights into the local regulatory scenario and personnel who are experienced and trained in these indications.

Our clinical trial experience includes, but is not limited to, the following indications:
  • Type I Diabetes
  • Type II Diabetes
  • Metabolic Syndrome
  • Hormone Deficiencies
  • Osteoporosis

Our investigator database consists of 190+ Diabetologists and Endocrinologists experienced in conducting studies in various Endocrinology/Diabetology indications and sites distributed across the major cities of India. We leverage our strong relationships with sites and investigators in the emerging markets of Asia & CEE to enable faster and cost effective clinical trial.

We have gathered detailed knowledge of feasibility of conducting clinical trials in the following indications:
  • Diabetes with Hypertriglyceridemia
  • Diabetes Type 2 with Mix Dyslipidemia
  • Diabetic Neuropathy
  • Type 2 Diabetes with Hypertension
  • Pediatric Type 2 diabetes
  • Goiter
  • Hypogonadism
  • Pediatric Type 2 diabetes

Additional Resources
Case Studies:
Diabetes Case Study

Asia Whitepaper
Diabetes Whitepaper